Quince

Quince Therapeutics Focuses on Advancing Innovative Precision Treatments for Debilitating and Rare DiseasesQuince Therapeutics is dedicated to advancing innovative precision treatments for debilitating and rare diseases. The company has discovered a broad bone-targeted drug platform designed to deliver small molecules, peptides, or biologics directly and precisely to fracture and disease sites, promoting faster healing compared to non-targeted therapies. Quince’s discovery pipeline aims to rapidly expand across multiple skeletal treatment indications to address underserved areas with unmet medical needs, including osteogenesis imperfecta, fractures, spinal fusion, and other severe bone disorders. The company’s lead compound, NOV004, is an anabolic peptide designed to precisely target and concentrate at fracture sites; preclinical studies indicate this results in direct and rapid increases in bone density, strength, and healing at the fracture site.